RU2006124746A - Имитаторы супероксиддисмутазы для лечения повреждения зрительного нерва и сетчатки - Google Patents
Имитаторы супероксиддисмутазы для лечения повреждения зрительного нерва и сетчатки Download PDFInfo
- Publication number
- RU2006124746A RU2006124746A RU2006124746/14A RU2006124746A RU2006124746A RU 2006124746 A RU2006124746 A RU 2006124746A RU 2006124746/14 A RU2006124746/14 A RU 2006124746/14A RU 2006124746 A RU2006124746 A RU 2006124746A RU 2006124746 A RU2006124746 A RU 2006124746A
- Authority
- RU
- Russia
- Prior art keywords
- group
- alkyl
- cycloalkenyl
- cycloalkyl
- alkynyl
- Prior art date
Links
- 210000005036 nerve Anatomy 0.000 title 1
- 230000000007 visual effect Effects 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims 18
- 125000003118 aryl group Chemical group 0.000 claims 18
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 12
- 125000000753 cycloalkyl group Chemical group 0.000 claims 12
- 125000002252 acyl group Chemical group 0.000 claims 10
- 125000003342 alkenyl group Chemical group 0.000 claims 10
- 125000004453 alkoxycarbonyl group Chemical group 0.000 claims 10
- 125000000304 alkynyl group Chemical group 0.000 claims 10
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 10
- 229910052736 halogen Inorganic materials 0.000 claims 10
- 150000002367 halogens Chemical class 0.000 claims 10
- 125000001072 heteroaryl group Chemical group 0.000 claims 10
- -1 heteroaryloalkyl Chemical group 0.000 claims 10
- 125000004366 heterocycloalkenyl group Chemical group 0.000 claims 10
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims 10
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 7
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 6
- 125000003277 amino group Chemical group 0.000 claims 6
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 6
- 150000001875 compounds Chemical class 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 4
- 125000004432 carbon atom Chemical group C* 0.000 claims 4
- 238000004177 carbon cycle Methods 0.000 claims 4
- 229910052757 nitrogen Inorganic materials 0.000 claims 4
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 4
- 229920006395 saturated elastomer Polymers 0.000 claims 4
- 125000004953 trihalomethyl group Chemical group 0.000 claims 4
- 102000019197 Superoxide Dismutase Human genes 0.000 claims 2
- 108010012715 Superoxide dismutase Proteins 0.000 claims 2
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical group [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 claims 2
- 150000001412 amines Chemical class 0.000 claims 2
- 150000001450 anions Chemical class 0.000 claims 2
- 150000001805 chlorine compounds Chemical class 0.000 claims 2
- 125000004404 heteroalkyl group Chemical group 0.000 claims 2
- 125000000623 heterocyclic group Chemical group 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 230000003278 mimic effect Effects 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 2
- 210000001525 retina Anatomy 0.000 claims 2
- 125000001424 substituent group Chemical group 0.000 claims 2
- RVEZZJVBDQCTEF-UHFFFAOYSA-N sulfenic acid Chemical group SO RVEZZJVBDQCTEF-UHFFFAOYSA-N 0.000 claims 2
- 201000002862 Angle-Closure Glaucoma Diseases 0.000 claims 1
- 206010021143 Hypoxia Diseases 0.000 claims 1
- 208000010038 Ischemic Optic Neuropathy Diseases 0.000 claims 1
- 206010030348 Open-Angle Glaucoma Diseases 0.000 claims 1
- 206010030924 Optic ischaemic neuropathy Diseases 0.000 claims 1
- 206010038848 Retinal detachment Diseases 0.000 claims 1
- 208000017442 Retinal disease Diseases 0.000 claims 1
- 206010038910 Retinitis Diseases 0.000 claims 1
- 208000007014 Retinitis pigmentosa Diseases 0.000 claims 1
- 206010038923 Retinopathy Diseases 0.000 claims 1
- 201000007058 anterior ischemic optic neuropathy Diseases 0.000 claims 1
- 210000001367 artery Anatomy 0.000 claims 1
- 230000007954 hypoxia Effects 0.000 claims 1
- 230000000642 iatrogenic effect Effects 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 208000028867 ischemia Diseases 0.000 claims 1
- 238000013532 laser treatment Methods 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000004264 retinal detachment Effects 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 239000000725 suspension Substances 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
- 210000003462 vein Anatomy 0.000 claims 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US52883003P | 2003-12-11 | 2003-12-11 | |
| US60/528,830 | 2003-12-11 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2006124746A true RU2006124746A (ru) | 2008-01-20 |
Family
ID=34710102
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2006124746/14A RU2006124746A (ru) | 2003-12-11 | 2004-11-30 | Имитаторы супероксиддисмутазы для лечения повреждения зрительного нерва и сетчатки |
Country Status (12)
| Country | Link |
|---|---|
| US (3) | US20070060557A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1691815A4 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2007513948A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20060101501A (cg-RX-API-DMAC7.html) |
| CN (1) | CN1889961A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2004305531B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0417549A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2545762A1 (cg-RX-API-DMAC7.html) |
| MX (1) | MXPA06006187A (cg-RX-API-DMAC7.html) |
| RU (1) | RU2006124746A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005060974A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA200603347B (cg-RX-API-DMAC7.html) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1889961A (zh) * | 2003-12-11 | 2007-01-03 | 爱尔康公司 | 用于治疗视神经和视网膜损伤的超氧化物歧化酶拟似物 |
| KR100724586B1 (ko) | 2005-12-09 | 2007-06-04 | 세종대학교산학협력단 | 수퍼옥사이드 디스뮤타아제 활성을 갖는 고리화합물 |
| US8598150B1 (en) | 2008-04-02 | 2013-12-03 | Jonathan R. Brestoff | Composition and method for affecting obesity and related conditions |
| US8987245B2 (en) | 2008-04-02 | 2015-03-24 | Jonathan R. Brestoff Parker | Composition and method for affecting obesity and related conditions |
| US20190388548A1 (en) * | 2018-06-26 | 2019-12-26 | Tzu Chi University | Method for providing ocular neuroprotection or for preventing, treating or alleviating the effects of, an ocular disease associated with retinal ganglion cell death |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4550022A (en) * | 1981-10-05 | 1985-10-29 | Alcon Laboratories, Inc. | Tissue irrigating solution |
| DE3773926D1 (de) * | 1987-07-22 | 1991-11-21 | Farvalsa Ag | Feuchtigkeitsstabile feste valproinsaeure-zubereitung und verfahren zu ihrer herstellung. |
| US6127356A (en) * | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
| US5994339A (en) * | 1993-10-15 | 1999-11-30 | University Of Alabama At Birmingham Research Foundation | Oxidant scavengers |
| SE9402816D0 (sv) * | 1994-08-24 | 1994-08-24 | Pharmacia Ab | Method and meams for drug administration |
| US6180620B1 (en) * | 1997-06-20 | 2001-01-30 | G.D. Searle & Co. | Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals |
| US6214817B1 (en) * | 1997-06-20 | 2001-04-10 | Monsanto Company | Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| AU5251999A (en) | 1998-08-04 | 2000-02-28 | Wisconsin Alumni Research Foundation | Method of reducing retinal ganglion cell degeneration |
| GB9817845D0 (en) * | 1998-08-17 | 1998-10-14 | Glaxo Group Ltd | Chemical compounds |
| WO2000023568A2 (en) | 1998-10-06 | 2000-04-27 | Albert Einstein College Of Medicine Of Yeshiva University | Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells |
| ES2240101T3 (es) | 1999-05-27 | 2005-10-16 | Monsanto Company | Biomateriales modificados con mimeticos de superoxido dismutasa. |
| DE60231246D1 (de) * | 2001-12-14 | 2009-04-02 | Alcon Inc | Superoxiddismutas-mimetika zur behandlung von augenerkrankungen |
| CN1889961A (zh) * | 2003-12-11 | 2007-01-03 | 爱尔康公司 | 用于治疗视神经和视网膜损伤的超氧化物歧化酶拟似物 |
-
2004
- 2004-11-30 CN CNA2004800367477A patent/CN1889961A/zh active Pending
- 2004-11-30 RU RU2006124746/14A patent/RU2006124746A/ru not_active Application Discontinuation
- 2004-11-30 EP EP04812365A patent/EP1691815A4/en not_active Withdrawn
- 2004-11-30 BR BRPI0417549-2A patent/BRPI0417549A/pt not_active IP Right Cessation
- 2004-11-30 KR KR1020067010078A patent/KR20060101501A/ko not_active Ceased
- 2004-11-30 MX MXPA06006187A patent/MXPA06006187A/es unknown
- 2004-11-30 JP JP2006543859A patent/JP2007513948A/ja active Pending
- 2004-11-30 US US10/575,911 patent/US20070060557A1/en not_active Abandoned
- 2004-11-30 WO PCT/US2004/039830 patent/WO2005060974A1/en not_active Ceased
- 2004-11-30 US US11/000,213 patent/US20050130951A1/en not_active Abandoned
- 2004-11-30 CA CA002545762A patent/CA2545762A1/en not_active Abandoned
- 2004-11-30 AU AU2004305531A patent/AU2004305531B2/en not_active Ceased
- 2004-11-30 ZA ZA200603347A patent/ZA200603347B/xx unknown
-
2010
- 2010-12-17 US US12/971,143 patent/US20110105453A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU2004305531A1 (en) | 2005-07-07 |
| WO2005060974A1 (en) | 2005-07-07 |
| AU2004305531B2 (en) | 2009-11-26 |
| EP1691815A4 (en) | 2010-03-31 |
| US20070060557A1 (en) | 2007-03-15 |
| US20110105453A1 (en) | 2011-05-05 |
| US20050130951A1 (en) | 2005-06-16 |
| CN1889961A (zh) | 2007-01-03 |
| ZA200603347B (en) | 2009-02-25 |
| MXPA06006187A (es) | 2006-08-25 |
| CA2545762A1 (en) | 2005-07-07 |
| EP1691815A1 (en) | 2006-08-23 |
| KR20060101501A (ko) | 2006-09-25 |
| JP2007513948A (ja) | 2007-05-31 |
| BRPI0417549A (pt) | 2007-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CO4810291A1 (es) | Composiciones fungicidas y metodos y compuestos y metodos para la preparacion de estos | |
| CA2405521A1 (en) | Macrocyclic ns3-serine protease inhibitors of hepatitis c virus comprising n-cyclic p2 moieties | |
| EA200600990A1 (ru) | Производные бензосульфониламинопиридин-2-ила и родственные соединения в качестве ингибиторов 11-бета-гидроксистероид-дегидрогеназы 1 типа (11-бета-hsd-1) для лечения диабета и ожирения | |
| AR087046A2 (es) | Compuestos derivados de 4-oxoquinolina | |
| BR0114044A (pt) | Prendedor de esclerótica e procedimentos para utilizar o mesmo | |
| KR900015729A (ko) | 흥분성 아미노산 길항제 | |
| KR870007137A (ko) | 치환 피리딘술폰아미드 화합물, 이들을 함유하는 제초 조성물 및 이들 화합물의 제조 방법. | |
| SK6532003A3 (en) | Ortho-substituted and meta-substituted bis-aryl compounds, method for the production thereof, their use as a medicament, and pharmaceutical preparations containing these compounds | |
| KR970702255A (ko) | 벤즈아미드 화합물 및 그의 약제학적 용도(benzamide compounds and pharmaceutical use thereof) | |
| CA2443918A1 (en) | Visual function disorder improving agents containing rho kinase inhibitors | |
| TW200745029A (en) | Sulfonamide derivatives exhibiting PGD2 receptor antagonism | |
| DE10061876A1 (de) | Arylierte Furan- und Thiophencarbonsäureamide, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament sowie sie enthaltende pharmazeutische Zubereitungen | |
| DK1031563T3 (da) | Sulfonylderivater | |
| RU2008130111A (ru) | (индазол-5-ил)пиразины и (1,3-дигидроиндол-2-он)пиразины для лечения опосредованнызх rно-киназой заболеваний и состояний | |
| NO20065494L (no) | Fuserte kinolinderivater og anvendelse derav | |
| TW200503692A (en) | Therapeutic agents | |
| DK1063228T5 (da) | Cycloalkenderivater, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| KR940005274A (ko) | 쇼그렌(Sjoegren)증후군 치료제 | |
| AR035196A1 (es) | Derivados de guanidina o biguanidina y el uso de los mismos para la fabricacion de medicamentos antivirales y antimicrobianos | |
| MX2024015383A (es) | Compuesto de amina ciclica de azacicloalquilcarbonilo | |
| RU2003105891A (ru) | Производные индола, способ их получения и их применение, лекарственное средство и способ лечения опухолевого заболевания млекопитающего | |
| HU9401161D0 (en) | Oxazolidone derivatives, process for producing them and pharmaceutical compositions containing them | |
| MY139586A (en) | Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives for reducing ichaemic damage | |
| CA2470721A1 (en) | Superoxide dismutase mimics for the treatment of ocular disorders and diseases | |
| MX2025001111A (es) | Nuevas sulfonamidas y su uso como agentes neuroprotectores y/o neurorrestauradores |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA92 | Acknowledgement of application withdrawn (lack of supplementary materials submitted) |
Effective date: 20090821 |